Navigation Links
Key factor in brain development revealed, offers insight into disorder
Date:3/26/2008

at role would be. Nor have they known what role, if any, the gene plays earlier on in brain development -- in neuroepithelial stem cells, themselves.

In their study, reported in the Feb. 8 issue of Cell, the scientists investigated embryonic mice genetically engineered to completely lack Lis1 in their cells at various stages of embryonic development. In a surprising finding, they discovered that Lis1 is essential for cell division in neuroepithelial stem cells. It also is important, though not essential, for cell division in the radial glial progenitor cells.

Lis 1, they showed, plays a critical role in ensuring that neuroepithelial stem cells divide symmetrically, so that both daughter cells receive the full set of duplicated chromosomes and the molecular components that support cell functions. It does so by helping regulate the orientation of the cells mitotic spindles -- the microtubules that draw the two sets of chromosomes into position on either side of the dividing mother cell and that demarcate, at their center, the cleavage point of cell division.

Specifically, Lis 1 makes sure that the mitotic spindle is oriented perpendicular to the top and base components of the neuroepithelial stem cells, so that each daughter cell not only receives the appropriate genetic material but also contains molecular components at the top and bottom, or the basal and apical, portion of the cell membrane, respectively.

In neuroepithelial stem cells, the apical and basal plasma membranes are only a tiny fraction of the total cell membrane, so the orientation of division must be precisely controlled either to make sure that both sides of each of the daughter cells are attached at both the apical and basal surfaces as they rapidly divide or to distribute apical and basal components equally to the daughter cells, says Wynshaw-Boris.

The scientists hypothesize that Lis1 carries out the role by directing the movement of a molecular mot
'/>"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Study, meta-analysis examine factors associated with death from heatstroke
3. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
4. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
5. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
6. Researchers genetically engineer micro-organisms into tiny factories
7. Study Downgrades Gene as Heart Risk Factor
8. Severe heart defect likely caused by genetic factors
9. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
10. Aggressively Treating Cardiac Risk Factors May Reverse Ischemia
11. New peptide communication factor enabling bacteria to talk to each other discovered
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Key factor in brain development revealed, offers insight into disorder
Key factor in brain development revealed, offers insight into disorder
(Date:11/21/2008)...UNTY, Calif., Nov. 21 Album Creati...irm, launches a new program offering big brand mar...aken the large, expensive ad agency process and se... a very hands-on approach," says Matt Parker, Crea... combines experience and proven brand-building tec...
(Date:11/21/2008)...eeting of shareholders to be held on January 8, 20...ll/ - Med-Emerg International Inc. ("MedEmerg") (O...health services, announced today that it has obtai...rt of Justice concerning its previously announced ...o which AIM Health Group Inc. ("AIM") will acquire...
(Date:11/21/2008)...G, Pa., Nov. 21 During...nor Edward G. Rendell today remembered Lieutenant ...er, an important partner in public service, and a ..., , "As the first woman elected lieutenant ... servant," said Governor Rendell. "Her family and ...
(Date:11/21/2008)..., Va., Nov. 21 The Gene...e following statement today from,GPhA President a... Commission,(FTC) roundtable on "Emerging Health ...he mere fact that the FTC is conducting this round...suring that consumers have access to safe and,aff...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...rs have pledged to identify children at risk in ho...ancy stage itself. // Minister Jack McConnell unve...rm - Next Steps to protect such children effective... to improve the identification of these children a...
...iament Wednesday approved a bill prohibiting smoki...hibits smoking in public groups, restaurants and e...f $12.5. It also restricts selling of cigarettes ... 18. Under the bill, an offender will have to pay ...
...ts major Female Health Company (FHC) has received ...le condoms //for India's state-run National AIDS C...sed in NACO's reproductive health and HIV/AIDS pre...ll initially be focused on commercial sex workers ...
...pointed out the alarming incidence of metabolic sy... official statistics, more than 25 million people,...ion face a high risk of heart attack and stroke. ...vernment health officials have stressed the need f...
Other Medicine News:Health News:US Firm To Supply Female Condoms To India 2
(Date:11/19/2008)...if., Nov. 19 Amgen,(Nas...Company, a subsidiary of,Takeda Pharmaceutical Co...nrollment in the Phase 3 MONET1 trial evaluating m... and carboplatin for the first-line treatment of,...en temporarily suspended,following a planned safe...
(Date:11/19/2008)..., Nov. 19 Biotech scientists incre...cology research to better understand the effects o...ems, reports Genetic Engineering & Biotechnol...in figuring out a new compound,s mechanism of acti...gy technique, according to the November 15 issue o...
(Date:11/18/2008)...9 NeuroDiscovery Ltd (AS...r and drug development Company,and Sosei Group C...eading,international biopharmaceutical company, t...urther pivotal pre-clinical efficacy data for NSL-...al therapy for neuropathic pain and has,successfu...
(Date:11/18/2008)...v. 18 Forty-two leading...vember national forum to consider cutting-edge inn...nd national economy from outbreaks of dangerous zo..., , Among those innovations: , , , ...tchen table that detects highly contagious and dan...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Chemical compound present in detergents produce bacteria alterations in agricultural soils 1148 1Chemical compound present in detergents produce bacteria alterations in agricultural soils 1148 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 1New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 2New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis 1146 3Researchers discover natural herbicide released by grass 1144 1Researchers discover natural herbicide released by grass 1144 2Educational media workshop unites cancer scientists and journalists 5857 1
...st clinical study of,HGS-ETR1 -, ROCKVILLE, Md., A...me Sciences, Inc. today reported that clinical and...ating that its TRAIL receptor,antibodies, HGS-ETR1...gnificant potential for use in the treatment of a ...1 and HGS-ETR2 could offer novel, highly,targeted ...
... - Insmed Inc.,(Nasdaq:INSM) today announced posi...d clinical study of the company,s drug,IPLEX(TM) i...ed,Adipose Redistribution Syndrome (HARS)., Prelim...he,University of California, San Francisco, showed...t in seven patients increased IGF-I,levels 3-fold ...
Other Medicine Technology:Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 2Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 3Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 4Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 5Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: